Unusual Late Relapse of ALK-Positive Anaplastic Large Cell Lymphoma Successfully Cleared Using the ALK-Inhibitor Crizotinib: Case Report

Overview of attention for article published in Frontiers in oncology, October 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 4 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 10,905 followers.

New research: Unusual Late Relapse of ALK-Positive Anaplastic Large Cell Lymphoma Successfully Cleared Using the ALK-Inhibitor Crizotinib: Case Report: Anaplastic large cell lymphoma (ALCL) with ALK-translocation constitutes an aggressive… https://t.co/cYh

07 Nov 2020

Reply Repost Favourite

RT @Lymphoma_Papers: Unusual Late Relapse of ALK-Positive Anaplastic Large Cell Lymphoma Successfully Cleared Using the ALK-Inhibitor Crizo…

03 Nov 2020

Reply Repost Favourite

Unusual Late Relapse of ALK-Positive Anaplastic Large Cell Lymphoma Successfully Cleared Using the ALK-Inhibitor Crizotinib: Case Report. #lymphoma #lymsm https://t.co/QhDwfkjKQ9

03 Nov 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.